Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis

Introduction. Diabetes mellitus, cardiovascular diseases and osteoporosis are linked by common pathophysiological mechanisms.Objective. To evaluate the effect of alendronate bisphosphonate on cardiovascular outcomes in comorbid patients with ischemic heart disease (CHD) associated with type 2 diabet...

Full description

Bibliographic Details
Main Authors: S. N. Shilov, E. N. Berezikova, A. A. Popova, E. N. Samsonova, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, A. V. Molokov, I. V. Yakovleva
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-05-01
Series:Медицинский совет
Subjects:
ischemic heart disease
diabetes mellitus
osteoporosis
bisphosphonates
alendronate
Online Access:https://www.med-sovet.pro/jour/article/view/6143

Internet

https://www.med-sovet.pro/jour/article/view/6143

Similar Items